Cargando…
Risk factors for the development of interstitial lung disease following severe COVID-19 pneumonia and outcomes of systemic corticosteroid therapy: 3-month follow-up
BACKGROUND: We aimed to evaluate the pulmonary involvement status, its related factors, and pulmonary function test (PFT) results in the first month follow up in patients who were discharged for severe Covid-19 pneumonia; and to assess the efficacy of corticosteroid treatment on these parameters in...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540725/ https://www.ncbi.nlm.nih.gov/pubmed/37712369 http://dx.doi.org/10.36141/svdld.v40i3.14418 |